95 related articles for article (PubMed ID: 15788682)
1. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Ma PC; Schaefer E; Christensen JG; Salgia R
Clin Cancer Res; 2005 Mar; 11(6):2312-9. PubMed ID: 15788682
[TBL] [Abstract][Full Text] [Related]
2. Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.
Calles A; Kwiatkowski N; Cammarata BK; Ercan D; Gray NS; Jänne PA
Mol Oncol; 2015 Jan; 9(1):260-9. PubMed ID: 25226813
[TBL] [Abstract][Full Text] [Related]
3. A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras.
Yang Y; Wislez M; Fujimoto N; Prudkin L; Izzo JG; Uno F; Ji L; Hanna AE; Langley RR; Liu D; Johnson FM; Wistuba I; Kurie JM
Mol Cancer Ther; 2008 Apr; 7(4):952-60. PubMed ID: 18413809
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.
Watson GA; Zhang X; Stang MT; Levy RM; Queiroz de Oliveira PE; Gooding WE; Christensen JG; Hughes SJ
Neoplasia; 2006 Nov; 8(11):949-55. PubMed ID: 17132227
[TBL] [Abstract][Full Text] [Related]
5. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752.
Smolen GA; Sordella R; Muir B; Mohapatra G; Barmettler A; Archibald H; Kim WJ; Okimoto RA; Bell DW; Sgroi DC; Christensen JG; Settleman J; Haber DA
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2316-21. PubMed ID: 16461907
[TBL] [Abstract][Full Text] [Related]
6. Macroporous hydrogel micropillars for quantifying Met kinase activity in cancer cell lysates.
Powers AD; Liu B; Lee AG; Palecek SP
Analyst; 2012 Sep; 137(17):4052-61. PubMed ID: 22814332
[TBL] [Abstract][Full Text] [Related]
7. Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.
Sima L; Wang Z; Yu L; Hou Y; Zhao D; Luo B; Liao W; Liu X
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286435. PubMed ID: 38078363
[TBL] [Abstract][Full Text] [Related]
8. TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death.
Zhang P; Chen Z; Li J; Mao H; Hu Y
Arch Biochem Biophys; 2024 Apr; 754():109925. PubMed ID: 38336254
[TBL] [Abstract][Full Text] [Related]
9. Correction: Phosphorylation of nucleoporin Tpr governs its differential localization and is required for its mitotic function.
Rajanala K; Sarkar A; Jhingan GD; Priyadarshini R; Jalan M; Sengupta S; Nandicoori VK
J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35344051
[No Abstract] [Full Text] [Related]
10. Somatic mutations lead to an oncogenic deletion of met in lung cancer.
Kong-Beltran M; Seshagiri S; Zha J; Zhu W; Bhawe K; Mendoza N; Holcomb T; Pujara K; Stinson J; Fu L; Severin C; Rangell L; Schwall R; Amler L; Wickramasinghe D; Yauch R
Cancer Res; 2006 Jan; 66(1):283-9. PubMed ID: 16397241
[TBL] [Abstract][Full Text] [Related]
11. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Frampton GM; Ali SM; Rosenzweig M; Chmielecki J; Lu X; Bauer TM; Akimov M; Bufill JA; Lee C; Jentz D; Hoover R; Ou SH; Salgia R; Brennan T; Chalmers ZR; Jaeger S; Huang A; Elvin JA; Erlich R; Fichtenholtz A; Gowen KA; Greenbowe J; Johnson A; Khaira D; McMahon C; Sanford EM; Roels S; White J; Greshock J; Schlegel R; Lipson D; Yelensky R; Morosini D; Ross JS; Collisson E; Peters M; Stephens PJ; Miller VA
Cancer Discov; 2015 Aug; 5(8):850-9. PubMed ID: 25971938
[TBL] [Abstract][Full Text] [Related]
12. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences and functional analysis of MET mutations in lung cancer.
Krishnaswamy S; Kanteti R; Duke-Cohan JS; Loganathan S; Liu W; Ma PC; Sattler M; Singleton PA; Ramnath N; Innocenti F; Nicolae DL; Ouyang Z; Liang J; Minna J; Kozloff MF; Ferguson MK; Natarajan V; Wang YC; Garcia JG; Vokes EE; Salgia R
Clin Cancer Res; 2009 Sep; 15(18):5714-23. PubMed ID: 19723643
[TBL] [Abstract][Full Text] [Related]
14. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
Onozato R; Kosaka T; Kuwano H; Sekido Y; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2009 Jan; 4(1):5-11. PubMed ID: 19096300
[TBL] [Abstract][Full Text] [Related]
15. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Engelman JA; Zejnullahu K; Mitsudomi T; Song Y; Hyland C; Park JO; Lindeman N; Gale CM; Zhao X; Christensen J; Kosaka T; Holmes AJ; Rogers AM; Cappuzzo F; Mok T; Lee C; Johnson BE; Cantley LC; Jänne PA
Science; 2007 May; 316(5827):1039-43. PubMed ID: 17463250
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma.
Zeng M; Liu C; Gong H; Tang Z; Wen J; Wang S; Xiao S
Front Mol Biosci; 2024; 11():1367331. PubMed ID: 38596618
[TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinases: biological functions and anticancer targeted therapy.
Zhang N; Li Y
MedComm (2020); 2023 Dec; 4(6):e446. PubMed ID: 38077251
[TBL] [Abstract][Full Text] [Related]
18. Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies.
Ayoub NM; Ibrahim DR; Alkhalifa AE
Med Oncol; 2021 Oct; 38(12):143. PubMed ID: 34665336
[TBL] [Abstract][Full Text] [Related]
19. A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells.
Chen W; Wu S; Huang Y; Zhang T; Dong H; Zheng X; Chen T; Gong X; Liu G; Zhao X
Onco Targets Ther; 2021; 14():4791-4804. PubMed ID: 34531665
[TBL] [Abstract][Full Text] [Related]
20. Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead.
Wu F; Zhuo L; Wang F; Huang W; Hao G; Yang G
iScience; 2020 Jun; 23(6):101179. PubMed ID: 32498019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
